Actively Recruiting
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
Led by Ospedale San Raffaele · Updated on 2024-05-16
40
Participants Needed
1
Research Sites
311 weeks
Total Duration
On this page
Sponsors
O
Ospedale San Raffaele
Lead Sponsor
F
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.
CONDITIONS
Official Title
Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a confirmed diagnosis of cystic fibrosis seen during routine clinical care according to standard procedures at the centers
- Both sexes
- Age over 18 years
- Provided informed consent according to study protocol procedures
You will not qualify if you...
- Patients unable to understand the study information and instructions or to adequately accept the study methods
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale San Raffaele
Milan, MI, Italy, 20132
Actively Recruiting
Research Team
N
Nicola I Lorè, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here